Market Access/ News/ News FDA approves AZ’s anifrolumab, ending 10-year lupus drug drought Phil Taylor anifrolumab, AstraZeneca, fda, lupus, lupus nephritis, regulatory approval, Saphnelo 0 Comment AstraZeneca has completed the resurrection of its anifrolumab drug for systemic lupus erythematosus (SLE) after claiming FDA approval Share X FDA approves AZ’s anifrolumab, ending 10-year lupus drug drought https://pharmaphorum.com/news/fda-approves-azs-anifromulab-ending-10-year-lupus-drug-drought/